Mapping Bromodomains in breast cancer and association with clinical outcome

por Pérez-Pena, Javier, Páez, Raquel, Nieto-Jiménez, Cristina, Sánchez, Verónica Corrales, Galan-Moya, Eva M., Pandiella, Atanasio, Győrffy, Balázs, Ocana, Alberto
Publicado 2019

Pathogenic Microenvironment from Diabetic–Obese Visceral and Subcutaneous Adipocytes Activating Differentiation of Human Healthy Preadipocytes Increases Intracellular Fat, Effect o...

por Alviz, Lesgui, Tebar-García, David, Lopez-Rosa, Raquel, Galan-Moya, Eva M., Moratalla-López, Natalia, Alonso, Gonzalo L., Nava, Eduardo, Llorens, Sílvia
Publicado 2021

Genomic Correlates of DNA Damage in Breast Cancer Subtypes

por Cabañas Morafraile, Esther, Pérez-Peña, Javier, Fuentes-Antrás, Jesús, Manzano, Aránzazu, Pérez-Segura, Pedro, Pandiella, Atanasio, Galán-Moya, Eva M., Ocaña, Alberto
Publicado 2021

Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene

por Noblejas-López, María del Mar, Morcillo-García, Sara, Nieto-Jiménez, Cristina, Nuncia-Cantarero, Miriam, Győrffy, Balázs, Galan-Moya, Eva M., Pandiella, Atanasio, Ocaña, Alberto
Publicado 2018

MZ1 co-operates with trastuzumab in HER2 positive breast cancer

por Noblejas-López, María del Mar, Nieto-Jiménez, Cristina, Galán-Moya, Eva M., Tebar-García, David, Montero, Juan Carlos, Pandiella, Atanasio, Burgos, Miguel, Ocaña, Alberto
Publicado 2021

The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity

por Dwyer, Julie, Azzi, Sandy, Leclair, Héloïse M, Georges, Steven, Carlotti, Agnès, Treps, Lucas, Galan-Moya, Eva M, Alexia, Catherine, Dupin, Nicolas, Bidère, Nicolas, Gavard, Julie
Publicado 2015

TACkling Cancer by Targeting Selective Protein Degradation

por Noblejas-López, María del Mar, Tébar-García, David, López-Rosa, Raquel, Alcaraz-Sanabria, Ana, Cristóbal-Cueto, Pablo, Pinedo-Serrano, Alejandro, Rivas-García, Lorenzo, Galán-Moya, Eva M.
Publicado 2023

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

por Noblejas-López, María del Mar, Nieto-Jimenez, Cristina, Burgos, Miguel, Gómez-Juárez, Mónica, Montero, Juan Carlos, Esparís-Ogando, Azucena, Pandiella, Atanasio, Galán-Moya, Eva M., Ocaña, Alberto
Publicado 2019

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer

por Corrales‐Sánchez, Verónica, Noblejas‐López, María del Mar, Nieto‐Jiménez, Cristina, Pérez‐Peña, Javier, Montero, Juan Carlos, Burgos, Miguel, Galán‐Moya, Eva M., Pandiella, Atanasio, Ocaña, Alberto
Publicado 2020

Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer

por Nieto-Jimenez, Cristina, Alcaraz-Sanabria, Ana, Martinez-Canales, Sandra, Corrales-Sanchez, Veronica, Montero, Juan Carlos, Burgos, Miguel, Nuncia-Cantarero, Miriam, Pandiella, Atanasio, Galan-Moya, Eva M., Ocaña, Alberto
Publicado 2020

Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors

por Morcillo-Garcia, Sara, Noblejas-Lopez, Maria del Mar, Nieto-Jimenez, Cristina, Perez-Peña, Javier, Nuncia-Cantarero, Miriam, Győrffy, Balázs, Amir, Eitan, Pandiella, Atanasio, Galan-Moya, Eva M., Ocana, Alberto
Publicado 2019

Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

por Noblejas-López, María del Mar, Gandullo-Sánchez, Lucía, Galán-Moya, Eva M., López-Rosa, Raquel, Tébar-García, David, Nieto-Jiménez, Cristina, Gómez-Juárez, Mónica, Burgos, Miguel, Pandiella, Atanasio, Ocaña, Alberto
Publicado 2022

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors

por Nieto-Jiménez, Cristina, Alcaraz-Sanabria, Ana, Pérez-Peña, Javier, Corrales-Sánchez, Verónica, Serrano-Heras, Gemma, Galán-Moya, Eva M., Serrano-Oviedo, Leticia, Montero, Juan Carlos, Burgos, Miguel, Llopis, Juan, Pandiella, Atanasio, Ocaña, Alberto
Publicado 2017

Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer

por Niza, Enrique, Noblejas-López, María del Mar, Bravo, Iván, Nieto-Jiménez, Cristina, Castro-Osma, José Antonio, Canales-Vázquez, Jesús, Lara-Sanchez, Agustín, Galán Moya, Eva M., Burgos, Miguel, Ocaña, Alberto, Alonso-Moreno, Carlos
Publicado 2019

Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC

por Galan-Moya, Eva M., de la Cruz-Morcillo, Miguel A., Valero, Maria Llanos, Callejas-Valera, Juan L., Melgar-Rojas, Pedro, Losa, Javier Hernadez, Salcedo, Mayte, Fernández-Aramburo, Antonio, Cajal, Santiago Ramon y., Sánchez-Prieto, Ricardo
Publicado 2011

ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy

por Aceves-Luquero, Clara I., Agarwal, Anupriya, Callejas-Valera, Juan L., Arias-González, Laura, Esparís-Ogando, Azucena, del Peso Ovalle, Luis, Bellón-Echeverria, Itxaso, de la Cruz-Morcillo, Miguel A., Galán Moya, Eva M., Gimeno, Inmaculada Moreno, Gómez, Juan C., Deininger, Michael W., Pandiella, Atanasio, Prieto, Ricardo Sánchez
Publicado 2009